Clinical trials
Phase 2 Lewy Body Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Axovant Sciences Ltd. | 5 |
| Georgetown University | 3 |
| EIP Pharma Inc | 2 |
| Eisai Inc. | 2 |
| Eli Lilly and Company | 2 |
| Aptinyx | 1 |
| Cognition Therapeutics | 1 |
| Columbia University | 1 |
| Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 1 |
| LeonaBio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lewy Body Disease | 20 |
| Parkinson Disease | 4 |
| Alzheimer Disease | 3 |
| Dementia | 3 |
| Cognitive Dysfunction | 2 |
| Hallucinations | 2 |
| REM Sleep Behavior Disorder | 2 |
| Brain Diseases | 1 |
| Cognition Disorders | 1 |
| Nervous System Diseases | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.